Gilead Sciences has battled back from a pipeline disappointment last year to its highest stock price in nearly a decade.

Q4 2024 Management View CEO Daniel O'Day highlighted strong Q4 results with total product sales, excluding Veklury, growing 13% year-over-year to $7.2 billion. Full-year sales reached $26.8 billion, ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

Adults in Tanzania living with HIV and taking tenofovir have a higher rate of chronic kidney disease vs. those without the ...

Gates said he "had a really good, very long dinner" with Trump at Mar-a-Lago after Christmas.

Women living in rural Appalachia who are at high-risk of HIV had effective interventions delivered through Facebook.

AIDS was first reported in the United States in 1981 and has since become a major worldwide epidemic (2 ). Most people infected with HIV experience a short, flu-like illness that can last from ...

Dec. 16, 2024 — A lab has completed a six-year study to examine the virulence of 38 clinical isolates from various strains of ... Analysis Reveals an Additional Mechanism Behind Statin Therapy's ...

This story was originally published by Healthbeat. Sign up for their public health newsletters at healthbeat.org/newsletters.

HIV infections have been falling in recent years, with just 1.3 million new cases recorded in 2023, a 60 per cent decline since the virus peaked in 1995.